Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer

Published:2017-02 Issue:2 Volume:208 Page:290-299
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Rauch Gaiane M.¹,Adrada Beatriz Elena²,Kuerer Henry Mark³,van la Parra Raquel F. D.³,Leung Jessica W. T.²,Yang Wei Tse⁴

Affiliation:

1. Department of Diagnostic Radiology, Unit 1473, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009.

2. Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, Houston, TX.

3. Department of Breast Surgical Oncology, Unit 1434, The University of Texas MD Anderson Cancer Center, Houston, TX.

4. Department of Diagnostic Radiology, Unit 1459, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.16.17223

Reference85 articles.

1. Translating neoadjuvant therapy into survival benefits: one size does not fit all

2. The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer

3. Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies

4. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

5. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes;Cancers;2024-07-29

2. Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?;European Radiology;2024-05-16

3. Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological response;European Radiology;2024-03-16

4. Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?;The Breast;2024-02

5. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept;Annals of Surgical Oncology;2023-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3